A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Viatris Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 301,316 shares of VTRS stock, worth $3.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
301,316
Holding current value
$3.77 Million
% of portfolio
0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.32 - $12.13 $3.11 Million - $3.65 Million
301,316 New
301,316 $3.5 Million
Q1 2024

May 13, 2024

BUY
$11.27 - $13.53 $1.1 Million - $1.32 Million
97,216 New
97,216 $1.16 Million
Q2 2023

Aug 11, 2023

SELL
$9.02 - $10.29 $18.2 Million - $20.8 Million
-2,019,550 Reduced 63.85%
1,143,597 $11.4 Million
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $4.07 Million - $5.43 Million
-442,916 Reduced 12.28%
3,163,147 $30.4 Million
Q4 2022

Feb 13, 2023

BUY
$8.72 - $11.56 $3.06 Million - $4.06 Million
351,363 Added 10.8%
3,606,063 $40.1 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $2.19 Million - $2.88 Million
258,450 Added 8.63%
3,254,700 $27.7 Million
Q2 2022

Aug 12, 2022

BUY
$9.95 - $12.27 $14.3 Million - $17.7 Million
1,438,584 Added 92.36%
2,996,250 $31.4 Million
Q1 2022

May 13, 2022

BUY
$9.81 - $15.4 $14.9 Million - $23.3 Million
1,515,366 Added 3582.43%
1,557,666 $16.9 Million
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $942,004 - $1.14 Million
-77,916 Reduced 64.81%
42,300 $572,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $12.5 Million - $14.3 Million
-945,400 Reduced 88.72%
120,216 $1.63 Million
Q2 2021

Aug 13, 2021

BUY
$12.97 - $16.15 $13.8 Million - $17.2 Million
1,065,616 New
1,065,616 $15.2 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.